A new review published in the journal Cardio-Oncology examines the growing burden of cardiovascular disease among cancer survivors. As survival rates for various cancers improve, mortality related to heart conditions in this population has risen. It is an open-access review that aims to clarify the challenges in understanding and managing the adverse cardiac effects of cancer therapies.
The review focuses on five cancers commonly encountered by general physicians. It explores the long-term cardiovascular risks associated with specific treatments, emphasizing the bidirectional relationship between cancer and cardiovascular disease. The authors critique current methods for assessing and stratifying cardiotoxicity risks. The review explores recent evidence and challenges in understanding and managing cardiotoxicity in respect of five cancers commonly encountered by the general physician. The study type is identified as a review, synthesizing recent evidence to inform clinical practice.
Cardio-oncology is described as an established subspecialty dedicated to the prevention and treatment of cardiac adverse effects from cancer therapies. The review outlines the cardiotoxic mechanisms involved in these interactions. It also addresses future directions for the prevention and management of heart issues in cancer patients. The authors recognize emerging evidence regarding the role of lifestyle measures in cardioprotection.
The version shared is an early access version of the peer-reviewed, accepted research. It is citable and carries a permanent DOI, though it is subject to further edits and will be replaced by the final Version of Record.
Subject of Research: Review of cardiotoxicity evidence and management in cancer survivors
Article Title: Cardiotoxicity in oncology: a cancer-centred perspective on current evidence and future directions
Article References: Brown, C., Ahmed, S., Zhang, H., Ding, J. L., Salam, A., & Rosen, S. D. (2026). Cardiotoxicity in oncology: a cancer-centred perspective on current evidence and future directions. Cardio-Oncology. https://doi.org/10.1186/s40959-026-00599-4
Image Credits: AI Generated
DOI: 10.1186/s40959-026-00599-4
Keywords: cardio-oncology, cardiotoxicity, cancer survivorship, cardiovascular disease, cancer therapy, risk assessment, clinical review, patient management, oncology, cancer-centred, perspective, current
News Source: Nathaniel Bowman. (November 7, 2026). Review Examines Cancer Therapy Heart Risks. Scienmag.
